Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 1541 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Revive Therapeutics Provides Update on its Cannabis-based Pharmaceuticals Initiatives

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  Revive Therapeutics Ltd

EyePoint Pharmaceuticals Announces Fiscal 2018 Fourth Quarter & Full Year Financial Results Release Date and Conference Call Information

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  EyePoint Pharmaceuticals

Stemline Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  Stemline Therapeutics, Inc.

ADMA Biologics Reports FDA Compliance Status for its Manufacturing Facility has Improved

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  ADMA Biologics, Inc.

Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  Adaptimmune Therapeutics plc.

Dermira Provides Launch Readiness Update for QBREXZA™ (glycopyrronium) Cloth for Primary Axillary Hyperhidrosis

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  Dermira Inc.

KemPharm to Present at Two Healthcare Investor Conferences During September 2018

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  KemPharm, Inc.

FDA Confirms Target Decision Date for Novel Single-Vial Formulation of EGRIFTA® (Tesamorelin for Injection)

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  THERATECHNOLOGIES, INC

Marinus Appoints Scott Braunstein, MD to its Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  Marinus Pharmaceuticals, Inc.

Arch Therapeutics Reports Topline Results from Skin Sensitization Study of AC5

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  Arch Therapeutics, Inc.

PetVivo Holdings, Inc. Welcomes Mr. Michael Haider as Senior Project Manager and Mr. Joel Hapke as Manager of Mfg., Analytical and Process Engineering

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018

Tyme Exceeds Enrollment Expectations for the Phase II Trial of SM-88 in Pancreatic Cancer

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  Tyme Technologies, Inc.

Biotricity Developing ECG Patch for Anticipated Q1 2019 Release

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  Biotricity Inc.

PhaseBio Secures $34 Million in Series D Financing

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  PhaseBio Pharmaceuticals Inc.

DiaMedica Therapeutics Announces the Appointment of Dr. Harry Alcorn Jr. as Chief Medical Officer

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  DiaMedica Therapeutics, Inc.

Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  Fibrocell Science Inc.

Tetra Bio-Pharma Secures CBD Supply Agreement for Genacol Partnership

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  Tetra Bio-Pharma Inc.

Inovio Doses 1st Subject in Phase 1/2 Clinical Trial For Vaccine Against Deadly MERS Infection

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  Inovio Pharmaceuticals Inc.

Yield10 Bioscience Reports Promising Seed Yield Results for Novel Yield Trait C3004 in Growth Chamber Studies in Camelina

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
Related companies:  Yield10 Bioscience, Inc.

Progressive Care Inc. CEO to Speak at First US FlyPharma Conference in Miami, Fla.

Read more ››
By: Nasdaq / GlobenewsWire - 05 Sep 2018
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑